All posts by: Michael Zand

About Michael Zand

Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-Cell – Jewish Business News

Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-CellJewish Business NewsStem cell therapies developer Gamida-Cell Ltd. has received an acquisition offer from an international pharma company, Novartis AG (NYSE:NVS; LSE: NOV; SWX: NOVZ). Elbit Medical Technologies, which has a 30.8 percent share in Gamida, said in a …Israel’s Gamida Cell gets buyout offer … Continue reading

2014-03-18 NEWS